Apim, Vaccibody and Targovax will present at ICCS prior to BIO in San Fransisco
Oslo Cancer Cluster will for the 5th time arrange International Cancer Cluster Showcase, ICCS in collaboration with leading cluster partners from Europe and North America. 20 oncology biotechs will pitch their latest innovations and partnering opportunities.
Member companies pitching at ICCS are Apim Therapeutics, Vaccibody and Targovax.
Oslo Cancer Cluster will not feature a booth this year, but International Advisor Jutta Heix will be present at BIO and participate in partnering meetings as well as CEO Ketil Widerberg,
